Technical Analysis for ORMP - Oramed Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade F 3.22 -0.62% -0.02
ORMP closed down 0.62 percent on Friday, March 22, 2019, on 17 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ORMP trend table...

Date Alert Name Type % Chg
Mar 22 20 DMA Support Bullish 0.00%
Mar 22 Bollinger Band Squeeze Range Contraction 0.00%
Mar 22 Upper Bollinger Band Walk Strength 0.00%
Mar 22 Down 3 Days in a Row Weakness 0.00%
Mar 21 Fell Below 50 DMA Bearish -0.62%
Mar 21 20 DMA Support Bullish -0.62%
Mar 21 Bollinger Band Squeeze Range Contraction -0.62%
Mar 21 Upper Bollinger Band Walk Strength -0.62%
Mar 21 BB Squeeze + Upper Band Touch Range Contraction -0.62%
Mar 21 Upper Bollinger Band Touch Strength -0.62%

Older signals for ORMP ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Oramed Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. The company's products primarily comprise ORMD0801, an oral insulin capsule that is in Phase II clinical trials for the treatment of diabetes; and ORMD0901, an analog for GLP-1 gastrointestinal hormone that is in per-clinical trials. Its portfolio of product candidates is based on intellectual property that allows for the protection of proteins and polypeptides in the stomach, and for their absorption through the gastrointestinal wall. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Jerusalem, Israel.
Medicine Chemistry Pharmaceutical Pharmaceutical Industry Diabetes Medication Pharmaceutical Industry In China Endocrine System Dosage Forms Insulin Peptide Hormones Treatment Of Diabetes Glucagon Like Peptide 1 Tablet Pharmaceutical Solutions
Is ORMP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 8.59
52 Week Low 2.78
Average Volume 37,469
200-Day Moving Average 4.535
50-Day Moving Average 3.2778
20-Day Moving Average 3.2198
10-Day Moving Average 3.2475
Average True Range 0.0899
ADX 14.57
+DI 19.3738
-DI 23.657
Chandelier Exit (Long, 3 ATRs ) 3.095
Chandelier Exit (Short, 3 ATRs ) 3.3697
Upper Bollinger Band 3.314
Lower Bollinger Band 3.1256
Percent B (%b) 0.5
BandWidth 5.851295
MACD Line -0.0051
MACD Signal Line -0.0148
MACD Histogram 0.0096
Fundamentals Value
Market Cap 42.89 Million
Num Shares 13.3 Million
EPS -0.95
Price-to-Earnings (P/E) Ratio -3.39
Price-to-Sales 59.88
Price-to-Book 6.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.31
Resistance 3 (R3) 3.31 3.28 3.30
Resistance 2 (R2) 3.28 3.26 3.28 3.29
Resistance 1 (R1) 3.25 3.24 3.24 3.25 3.28
Pivot Point 3.22 3.22 3.21 3.22 3.22
Support 1 (S1) 3.19 3.20 3.18 3.19 3.16
Support 2 (S2) 3.16 3.18 3.16 3.15
Support 3 (S3) 3.13 3.16 3.15
Support 4 (S4) 3.13